SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D3A5A247CA06D94744B0E42A09124A38255347B109ADF687D0BF9953BED33EDDE6EB9527BFF1EF9A045C1CCD3D214271>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D3A5A247CA06D94744B0E42A09124A38255347B109ADF687D0BF9953BED33EDDE6EB9527BFF1EF9A045C1CCD3D214271
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D3A5A247CA06D94744B0E42A09124A38255347B109ADF687D0BF9953BED33EDDE6EB9527BFF1EF9A045C1CCD3D214271
http://www.w3.org/2000/01/rdf-schema#comment
"These findings suggest that increased plasma VEGFA and reduced PLGF correlate with clinical severity of pulmonary vascular disease and may be associated with adverse outcome in CDH."
xsd:string
http://purl.uniprot.org/uniprot/#_5C16D5C72CBB9CE2E7918147FE51896EFBEC16D1760B6ED637B764C6D869DF757600E471EDB90619F2AF13C8E9055B50
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D3A5A247CA06D94744B0E42A09124A38255347B109ADF687D0BF9953BED33EDDE6EB9527BFF1EF9A045C1CCD3D214271
http://purl.uniprot.org/uniprot/G3XA84
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D3A5A247CA06D94744B0E42A09124A38255347B109ADF687D0BF9953BED33EDDE6EB9527BFF1EF9A045C1CCD3D214271
http://purl.uniprot.org/uniprot/#_G3XA84-mappedCitation-25480334
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D3A5A247CA06D94744B0E42A09124A38255347B109ADF687D0BF9953BED33EDDE6EB9527BFF1EF9A045C1CCD3D214271